{"schema_version":"secwatch.filing_event.v1","accession":"0001522767-23-000009","form_type":"8-K","ticker":"MRMD","cik":"0001522767","company_name":"MARIMED INC.","filed_at":"2023-03-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.380558+00:00","generated_at":"2026-06-18T17:51:13.080174+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"MariMed Q4 revenue up 15.5% YoY to $35.8M; net income turns positive but EBITDA margin shrinks","bullets":["Q4 revenue $35.8M (+15.5% YoY); full-year revenue $134.0M (+10.3% YoY).","GAAP net income Q4 $4.8M vs loss of $6.4M in prior year; full-year net income $13.6M (+79% YoY).","Non-GAAP adjusted EBITDA Q4 $4.5M (down 46% YoY); full-year $32.4M (down 24% YoY).","GAAP gross margin Q4 44% vs 50% prior year; full year 48% vs 55%.","CEO: positive cash flow from ops for third consecutive year; expects accelerated growth in 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001522767-23-000009","json":"https://secwatch.observer/filing/0001522767-23-000009.json","markdown":"https://secwatch.observer/filing/0001522767-23-000009.md","text":"https://secwatch.observer/filing/0001522767-23-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1522767/000152276723000009/0001522767-23-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1522767/000152276723000009/mrmd-20230301.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T17:51:13.080174+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"513bdfce8442920c06c22144dc697a141deee8c1","claim":"MARIMED INC. reported year ended December 31, 2022 results: revenue $134.0, net income $13.6.","evidence_excerpt":"2022 and 2021 (in millions, except percentage amounts): Financial Highlights 1 Three months ended Year ended December 31, December 31, 2022 2021 2022 2021 Revenue $ 35.8 $ 31.0 $ 134.0 $ 121.5 GAAP Gross margin 44 % 50 % 48 % 55 % Non-GAAP Gross margin 45 % 50 % 48 % 55 % GAAP Net income (loss) $ 4.8 $ (6.4) $ 13.6 $ 7.6 Non-GAAP Net income $ 5.2 $ 0.1 $ 22.2 $","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1522767/000152276723000009/0001522767-23-000009-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"year ended December 31, 2022"},{"label":"Revenue","value":"$134.0"},{"label":"Net income","value":"$13.6"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"90d8ed69bd79735c97188d117a0a5a30f311b133","claim":"MARIMED INC. reported three months ended December 31, 2022 results: revenue $35.8, net income $4.8.","evidence_excerpt":"December 31, 2022 and 2021 (in millions, except percentage amounts): Financial Highlights 1 Three months ended Year ended December 31, December 31, 2022 2021 2022 2021 Revenue $ 35.8 $ 31.0 $ 134.0 $ 121.5 GAAP Gross margin 44 % 50 % 48 % 55 % Non-GAAP Gross margin 45 % 50 % 48 % 55 % GAAP Net income (loss) $ 4.8 $ (6.4) $ 13.6 $ 7.6 Non-GAAP Net income $ 5.2","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1522767/000152276723000009/0001522767-23-000009-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended December 31, 2022"},{"label":"Revenue","value":"$35.8"},{"label":"Net income","value":"$4.8"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}